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Abstract
Cardiovascular diseases (CVDs) are still a major cause of mortality worldwide 
and are a serious health problem. Various factors that contribute toward CVDs 
include hypertension, tobacco use, physical inactivity, diabetes mellitus, obesity 
and overweight, alcohol, dietary factors and psychosocial aspects such as stress, 
anxiety and depression. Nutraceuticals and diet are very important for prevention 
of CVDs. The potential of nutraceuticals or functional food in mitigating risk of 
CVDs is discussed. Functional food with health related properties include fruit and 
vegetable, fish, legumes, nuts, soya protein, coffee, tea, chocolate, animal based 
functional food. In addition, some diet plans have shown the potential of reducing 
the incidence of CVDs. This includes the Mediterranean, Dietary Approaches to 
Stop Hypertension (DASH), Okinawan and vegetarian diets. This chapter examines 
the risk factors of CVDs, including hypertension, tobacco usage, physical inactiv-
ity, diabetes mellitus, overweight and obesity. The chapter also brings to the fore, 
functional foods with properties related to health and effect of dietary patterns in 
the treatment and prevention of CVDs.
Keywords: non-communicable disease, cardiovascular diseases, nutraceutical, 
functional foods, dietary patterns
1. Introduction
Globally, non-communicable diseases (NCDs) account for 73% of all death 
with cardiovascular diseases (CVDs) and ischemic heart disease (IHD) as the main 
contributors of cardiovascular mortality in 2017 [1]. Cardiovascular, respiratory as 
well as associated disorders (CVRDs) are predominant subgroup of NCDs and are 
major causes of morbidity and mortality in developing and developed countries. 
In 2012, it was estimated that 55.9 million people died around the world and NCDs 
accounted for 37.9 million of those deaths. Specifically, CVRDs led to 23.9 million 
deaths [2]. Table 1 shows the impact of CVRDs on the total deaths in different coun-
tries based on the income group. Cardiovascular diseases killed 17.5 million; respira-
tory diseases led to 4.0 million deaths; diabetes mellitus to 1.5 million and diseases 
related to kidney accounted for 864 000 deaths, respectively [4]. In addition, NCDs 
account for about 35% (around 2.6 million) of all deaths in sub-Saharan Africa and 
this makes NCDs the second most common cause of death after a combination of 
communicable, maternal, neonatal, and nutritional related diseases [5]. Researchers 
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estimate that more than three-quarters of deaths will be due to NCDs by the end of 
2030 and more deaths in developing countries will be attributed to CVDs alone than 
contagious diseases such as malaria, tuberculosis and HIV/AIDS [6].
Cardiovascular diseases are complex and composite diseases that are character-
ised by high serum lipids and triglycerides, cholesterol, elevated plasma fibrinogen 
and agglomeration factors with increased production of platelet as well as distur-
bance in metabolism of glucose [7, 8]. They are a broad category of diseases involv-
ing the heart and blood vessels causing coronary artery diseases such as angina 
which can lead to heart attack, heart failure, hypertensive heart diseases, stroke, 
and many other problems. [9]. Cardiovascular diseases are still the leading cause of 
mortality globally leading to 12.3 million and 17.6 million deaths in 1990 and 2016, 
respectively [10–12]. Stroke and coronary artery disease result in of 80% and 75% 
CVD deaths in male and females, respectively [12].
Various epidemiological studies have demonstrated that diet habits and healthy 
life style might prevent chronic diseases such as CVDs but poor habits aggravate 
these diseases [8, 13]. Individuals that consume large amount of fruits, vegetables 
and sea food are less vulnerable to CVDs incidence [14]. The role of dietary factors 
such as sodium and saturated fats known to increase the risk of CVDs has been 
substantially explored [15]. The perception that food does not only furnish fun-
damental nutrition but can also play a role in preventing diseases and assure good 
health and life is now gaining attention. High intake of food that is calorie dense, 
poor nutrition, highly processed and easy to absorb food can contribute to inflam-
mation of system, low insulin vulnerability as well as a group of metabolic diseases 
which include obesity, high blood pressure, dyslipidemia, and diabetes mellitus 
[16]. Food that furnish a health benefits apart from basic nutrition such as reducing 
high blood total cholesterol as well as low-density lipoprotein cholesterol are called 
functional foods.
2. Risk factors for cardiovascular diseases
The traditional risk factors for CVDs (Table 2) have been extensively researched 











Population 850000 2510000 2430000 1290000 7060000
Total deaths 7450 19900 16900 11700 55900
CVRD deaths 1540 7780 9080 5530 23900
CVRD deaths 21% 39% 54% 47% 43%
CVRD death by cause
CVDs 999 5220 6860 4440 17500
DM 135 549 559 254 1497
RD 309 1630 1460 645 4040
Kidney diseases 99 378 197 190 864
Note: CVRD = Cardiovascular, respiratory, and related disorder, CVDs = Cardiovascular diseases, DM = Diabetes 
mellitus, RD = Respiratory disorder. [2, 3].
Table 1. 
Impact of CVRDs on the total deaths in different countries based on the income group in 2012. Thousands, 
unless otherwise noted.
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as hypertension and dyslipidemia. However, the dietary factor phenomenon has 
not been fully investigated [3]. A 2011 global report indicated that hypertension 
contributed to 13% of CVDs deaths, tobacco 9%, physical inactivity 6%, diabetes 
mellitus 6% and obesity 5% of global deaths [19, 20].
2.1 Hypertension
Hypertension is systolic blood pressure values ≥140 mmHg and/or diastolic 
blood pressure values ≥90 mmHg. The relationship between hypertension and 
CVDs has been investigated in different studies [21, 22]. Hypertension exhibits an 
independent interminable relationship with the incidence of various CVDs such 
as stroke, heart failure and peripheral arterial [23, 24]. Hypertension is commonly 
without symptoms which silently damage the arteries that furnish the heart, brain, 
kidneys and other vital organs with blood and produce various structural changes. 
Various epidemiological, animal and genetic studies have confirmed that excessive 
intake of sodium increases blood pressure. For example, excessive consumption 
of sodium (>5 g sodium per day as defined by World Health Organisation) [25] 
produces a significant rise in hypertension and is associated with the onset of 
hypertension and its cardiovascular complications [26, 27]. By contrast, low intake 
of sodium reduces hypertension prevalence and is associated with low cardiovas-
cular morbidity and mortality rate [28]. As a result, a common nutritional plan 
to minimise the incidence of hypertension includes achieving and maintaining 
a healthy body weight; consumption of a diet rich in minerals such as calcium, 
phosphorus, and magnesium as well as moderate consumption of alcoholic bever-
ages and sodium [29].
2.2 Tobacco use
There are more than one billion smokers around the world and in 2013, tobacco 
usage accounted for more than 6.1 million deaths [18]. This estimation covers 
vulnerability to passive smoking (second hand smoke) which increases CVDs risk 
by 25 to 30% and public smoking bans substantially decrease the rate of heart 
attacks [30]. The most smoked form of tobacco is cigarette. More than 80% of 
tobacco users live in lower middle income countries and this number is expected to 
increase in the next decade [31]. Most smokers in lower middle income countries are 
male but this is not the case in high income countries. Early cessation of smoking 
contributes to substantial lower incidence of reinfarction within 1 year in patients 
who have had a heart attack and decreases the possibility of instant cardiac death in 
Non-modifiable Metabolic Lifestyle Novel
Family history Diabetes mellitus Diet Oxidative stress
Advancing age Obesity Smoking High homeostatic factors
Family history Hypertension Physical activity Small dense low density 
lipoprotein-C
Hyperlipidemia High lipoprotein level




Risk factors of cardiovascular diseases.
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patients with CVDs [32]. There are two CVDs challenges associated with the use of 
tobacco products. Firstly, the rate of smoking is higher in the poorest populations 
of the world [33] and the second problem is smoking among girls [34]. The risk of 
IHD to tobacco smokers is 2–3 times higher than non-smokers, stroke is 1.5 times 
higher and lung cancer is 12 times higher. These risks are related to age gradient, 
with younger age group having higher relative risk (5–6 times) and these are similar 
for men and women [35].
2.3 Physical inactivity
The World Health Oranisation highlighted the fact that one in four adults is not 
physical active enough across the globe and the challenge of reduced physical activ-
ity increases as the income of a country increases [36]. Low physical activity even-
tually leads to obesity which has gradually increased throughout the past decades 
both in developing and developed countries. Low rate of atherosclerotic process, 
including improvement of endothelial dysfunction, low systematic inflammation 
and stroke that go along with physical activity, could explain the protective role of 
physical activity on CVDs risk [37]. Numerous epidemiologic studies conducted 
with non-identical and big populations have demonstrated that physical activity has 
protective effect on coronary arteries disease. For example, physical activity reduces 
blood pressure and the prevalence of hypertension by reducing vascular resistance 
and terminating the action of the sympathetic nervous and the renninangiotensin 
systems. Figure 1 shows the possible channels of physical activity that assist in 
decreasing the likelihood of CVDs. In 41837 women of age group between 55 and 
69 years, Folsom et al. [38] study found that hypertension incidence decreased by 
10% and 30% in participants with moderate and higher levels of physical activity 
than those with low levels of physical activity. The biological pathways support 
the usefulness of physical activity in decreasing the likelihood of stroke including 
ischemic and hemorrhagic. The possible ramifications on the likelihood of ischemic 
might be due to the mechanisms that reduce the development of atherosclerotic; 
while the possible ramifications on the likelihood of hemorrhagic stroke disease 
might be attributed to low blood pressure as well as additional associated risk 
factors. Nonetheless, there are conflicting findings from different studies about 
the relationship of physical activity and the incidence of stroke, with few studies 
showing relationships or no relationships [39, 40]. These disagreements are likely 
the result of the type of the study design, population, definition and evaluation of 
physical activity of the different studies.
2.4 Diabetes mellitus
Diabetes mellitus (DM) is caused by insufficient production of insulin by the 
pancreas or resistance by end-organ tissues and presents as a high blood glucose. 
There are three types of DM, namely, type 1, type 2, and gestational diabetes. Type 
1 DM is an autoimmune disorder and usually takes place in early childhood and 
adolescents, gestational DM occurs during the second or third trimester of preg-
nancy, increases the future risk of those patients to type 2 DM [41–43]. Type 2 DM, 
the most common form accounts for 90–95% of diagnosed DM and continues to be 
rapidly growing worldwide and in the USA [44]. Globally, the prevalence of DM is 
escalating and its incidence in 1985 was 20 million compared to 382 million in 2014 
[45]. The current estimation by the International Diabetes Federation expects that 
592 million people will have DM by 2035 [46]. China and India have highest number 
of people with diabetes estimated at 69 million and 109 million, respectively and 
these numbers are expected to rise to 123 million and 150 million by 2040 [47]. A 
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close association exists between DM and CVDs. The most familiar cause of mortal-
ity and morbidity in diabetic patients is CVDs since DM results in complications 
of both microvascular and macrovascular. Complications such as IHD, ischemic 
stroke, and amputations because of foot infections are examples of macrovascular. 
The comparative risk for CVDs morbidity and mortality in adults with DM var-
ies from 1 to 3 in men and from 2 to 5 in women to those with no DM [48]. Many 
diabetic patients die due to IHD or stroke and both are often registered as the 
cause of death, not DM [2]. A number of evidences exist that demonstrate that the 
relationship of type 2 DM and associated cardiovascular risk promote the progres-
sive nature of the vascular damage, leading to atherosclerosis [49]. Cardiovascular 
deaths account for 44% of death in those with type 1 DM and 52% of deaths in type 
2 DM [50]. Debate still remains if the relationship between DM and CVD is associ-
ated with diabetes status itself or the risk factors diabetic patients are prone to.
2.5 Obesity and overweight
According to the World Health Organisation data, 39% of the global popula-
tion above 18 years of age is overweight and of these, 13% are obese. Obesity is an 
abnormal or excessive fat accumulation in adipose tissue to the degree that health 
might be compromised [51]. Obesity increases the risk for CVDs since it increases 
the load of the atherosclerotic plaques, characterised by significant infiltration of 
macrophage and plaque fluctuation [52]. People who accumulate abnormal body 
Figure 1. 
Possible mechanisms of physical activity that help in decreasing CVDs risk [37].
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fat, particularly at the waist, are at higher risk to have stroke and heart disease 
even if they do not have other risk factors. The incidence of overweight and obesity 
among adults in low-income countries varies from 4.7–21.0% and from 13.0–42.7% 
in upper-middle-income countries [53]. Different studies have demonstrated 
association between obesity and CVDs such as heart failure and cardiac death. 
Accumulation of abnormal body fat leads to various metabolic changes that increase 
the common risk factors of CVDs and affects systems modulating inflammation 
[54]. Recent studies have demonstrated that weight loss in individuals who are 
overweight and obese reduces the incidence of diabetes and CVDs. The benefit of 
weight reduction in overweight and obese individuals with or without hyperten-
sion is low blood pressure and serum triglycerides, and increased high-density 
 lipoprotein [55, 56].
3. Nutraceuticals and functional foods
Nutraceutical foods, a borderline between food and drugs, are conventional or 
processed foods that have or added a useful food component which has a health 
beneficial effect [57, 58]. Nutraceuticals foods provide medicinal and health ben-
efits and these include prevention, management and/or treatment of a disease. 
Examples of nutraceutical foods are isolated nutrients, dietary supplements, func-
tional foods, medicinal products and processed foods such as cereals, beverages and 
soups [59, 60]. The interest of nutraceuticals in prevention of CVDs was invigorated 
after the examinations of a proximate relationship between their consumption, as 
shown by higher levels of plasma and low CVDs incidence [61, 62]. Japan is the first 
country that introduced functional foods in the 1980s and is the only country that 
has distinct regulatory system that approves functional foods [58]. Functional foods 
contain dietary fibres, polyphenolic compounds, herbs and botanicals and oligosac-
charides with their correlating health benefits [63]. It is believed that functional 
foods use their cardio-protective effects mostly via antioxidant actions which lower 
blood lipid levels.
The following factors differentiate functional foods from dietary supplements: 
(1) Functional foods are expected not to only supplement the diet but should also 
play a role to prevent and/or treat disease(s) and (2) Functional foods are utilised 
as traditional foods or as exclusive items of a meal or diet [64]. Dietary components 
play useful roles apart from basic nutrition and this led to the development of 
nutraceuticals and functional food concept [65]. Functional foods have different 
mechanism of actions, such as decreasing low density lipoprotein and elevated 
blood total cholesterols [66].
3.1 Functional foods with health related properties
Different functional foods are beneficial in preventing and treating CVDs 
(Table 3). Dietary fibres of fruit (with pectin) and vegetable, fish oil and oily 
seeds such as walnut, almond and many others lower the lipid levels in humans 
and this is attributed to both prevention of fat absorption and termination of 
synthesis of hepatic cholesterol [81]. A higher consumption of whole grains, 
bioactive compounds, antioxidants vitamins and folic acid appears to reverse 
the harmful vascular effects of homocysteine in the heart [82, 83]. A substantial 
cardiovascular benefit of polyphenolic compounds, vitamins (ascorbic acid, 
vitamin E), and minerals such as selenium and magnesium in food is thought 
to be the ability of these components to scavenge free radicals generated during 
atherogenesis [84, 85].
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3.1.1 Fruits and vegetables
There is significant amount that low intake of fruit and vegetable is related to 
higher risk of CVDs while higher intake is related to low risk of CVDs [86, 87]. Fruits 
and vegetables are rich sources of polyphenolic compounds such as phenolic acid and 
flavonoids. Different studies associate the intake of polyphenols foods such as fruit 
and vegetable with low risk of CVDs [88, 89]. In addition, various studies have shown 
that the properties of flavonoids such as antioxidants and anti-inflammatory might 
also improve functions of vascular system [90, 91]. Fruits and vegetables reduce 
Functional 
food
Active component Mechanism of action Reference
Fruit and 
vegetable
Antioxidant vitamins, dietary 
fibre, carotenoid, polyphenolic 
compounds
Lower concentrations of 
the inflammatory mediator 
C-reactive protein
Decrease low density lipoprotein





Dietary fibre, minerals, B vitamins 
and polyphenols






Mono and polyunsaturated fatty 
acids, arginine, soluble fibre, 
polyphenols, folic acid and B 
vitamins
Lower blood cholesterol
Reduce post-prandial vascular 
reactivity
Improved endothelial function
Reduce concentrations of blood 
homocysteine
Lower myocardial infarction
Positive effect on blood pressure
[71–73]
Fish Omega 3 fatty acids Improve endothelial function
Lower blood pressure and heart 
rate
Reduce aggregability of platelet
Reduce fatal cardiac arrhythmias
Anti-inflammatory
[74]
Soy protein Isoflavonoids, dietary fibre, 
polyunsaturated fatty acids, 
vitamins and minerals,
Reduce total cholesterol and low 
density lipoprotein-C levels






Diterpenes (kahweol and cafestol) Myocardial infarction [78]
Chocolate Flavonoids Improve NO-dependent
Vasorelaxation
Improve flow-mediated dilation 
in the brachial arteries
Reduce ambulatory serum low 
lipoprotein-C levels and
blood pressure
Decrease blood cholesterol levels
Increase high density 
lipoprotein-C




Different functional foods beneficial in preventing and treating CVDs.
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the risk of CVDs by decreasing vulnerability of low density lipoprotein particles to 
oxidation [92]. Different types of bioactive compounds found in fruits and vegetables 
such as dietary fibre, carotenoids, ascorbic acid and minerals such as magnesium and 
potassium act collaboratively to nurture a comprehensive beneficial effect.
3.1.2 Whole grains, legumes and nuts
Whole grains are more important in terms of nutrition since they have phy-
tochemicals that could work synergistically to decrease the risk of CVDs [93]. 
Moreover, whole grains are also a rich source of dietary fibre, vitamin B complex 
and minerals. The preventative effect of whole grains on the risk of CVDs is attrib-
uted to their influence on insulin vulnerability, blood pressure and inflammation 
which is associated with the excessive consumption of antioxidant nutrients avail-
able in the germ of whole grains [83, 94, 95]. Legumes are rich source of protein, 
soluble fibre, micronutrients such as folate and polyphenols [96]. Different bioac-
tive components such as protein, dietary fibre and phytosterols are attributed to 
the cholesterol-lowering effect of legumes [97]. Nuts are rich sources of mono and 
polyunsaturated fatty acids, arginine, soluble fibre and various antioxidant poly-
phenols and these active components contribute to cholesterol lowering effects [71].
3.1.3 Fish
High consumption of fish and fish oil supplements contribute to low incidence 
of CVDs [98]. Fish is a rich source of omega 3 fatty acids such as docosahexaenoic 
acid (DHA; 22:6 n-3) and eicosapentaenoic acid (EPA; 20:5 n-3). They are avail-
able in oily fish such as salmon, tuna, herring and fish oil. Consumption of fish is 
associated with low risk for myocardial infarction, which is associated with useful 
influence of DHA and EPA on plaque fluctuation and modulation of endothelial 
function [99]. Fish oil supplements have beneficial influence on blood pressure and 
lipid profile [100, 101]. Moreover, DHA and EPA reduce low density lipoprotein 
oxidative sensitivity in postmenopause women which might assist in reducing the 
risk of CVDs [102].
3.1.4 Soy protein
Soy products are a rich source of polyunsaturated fatty acids, dietary fibre, 
micronutrients, low saturated fat content and isoflavones [103]. In addition, the 
protein content of soybean ranges from 35%–40% having all essential amino acids 
making soy protein comparable to protein of animal source and it is also cholesterol 
free [104]. Isoflavones prevent the oxidation of low density lipoprotein and reduces 
the risk of atherosclerosis [76]. Studies done in China among women and Japan 
demonstrated that a daily consumption of more than 6 g of soy reduces low density 
lipoprotein-C, total cholesterol, ischaemic and cerebrovascular incidence than 
consumption of less than 0.5 g [105, 106].
3.1.5 Coffee, tea and chocolate
Coffee and tea, the most popularly consumed beverages after water, are the 
chief source of caffeine. Diterpenes such as kahweol and cafestol are suspected to be 
behind the cardio-protective effect of coffee. Consumption of coffee might poten-
tially decrease the incidence of myocardial infarction, but evidence in this regard 
is not conclusive [107, 108]. Although results are not consistent, consumption of 
green tea seems to protect against CVDs [109]. High intake of tea and flavonoids 
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contribute to the primary prevention of IHD and reduced risk of CVDs mortality 
[109, 110]. Cocoa is the main ingredient in chocolate manufacturing; it is a rich 
source of flavonoid and it has been lately evaluated for its plausible role in prevent-
ing CVDs [111]. The protective effect of chocolate is attributed to the decrease of 
blood cholesterols levels, substantial increase of high density lipoprotein including 
marked decrease of oxidised low density lipoprotein [112].
3.1.6 Animal based functional food
Meat and dairy products are major source of fat in the diet, particularly satu-
rated fatty acids (SFA) which is the leading cause of total cholesterol and CVDs. 
Meat contains a lot of fat with more than 40% in saturated form, therefore, its 
quantity and quality has been changed to create new meat products of functional 
properties. Three meat reformulation methods were proposed in order to develop 
the functional meat products, namely, low total fat, low total cholesterol intake 
and modification of fatty acid profile [113]. Dairy products are related to numer-
ous negative health effects because of earlier observations associated SFA content, 
which might result into increased low-density lipoprotein levels, which in turn 
increases the risk of CVDs [114]. Dairy products have high SFA and their consump-
tion has long been implicated in contributing to the development of CVDs [115]. 
Therefore, the consumption of low-fat or non-fat dairy products has been recom-
mended to reduce the risk of CVDs development. Nevertheless, studies tend to 
show that intake of whole-fat dairy has a favourable effect on health of cardiovas-
cular system and might be more beneficial than intake of low-fat dairy, especially 
in connection with inflammatory markers. Recent several meta-analyses have 
demonstrated that low-fat dairy products and whole milk are associated with lower 
risk of hypertension [116–118]. The presence of calcium, vitamin D as well as other 
bioactive components such as peptides in dairy products is related to lower blood 
pressure irrespective of the fat content [119, 120]. High intake of fermented dairy 
products is associated with low density lipoprotein, low risk of hypertension and 
CVDs [121, 122]. Consumption of cheese is associated with a low risk of stroke and 
CVDs [123]. Moreover, consumption of yoghurt is also related to lower risk of CVDs 
[124]. The presence of bioactive lipids and peptides that have anti-inflammatory 
characteristics might have contributed to these effects as well as calcium in cheese 
which might reduce the intake of SFA, thereby decreasing the risk of high cholester-
ols levels [114]. Moulded cheeses such as Camembert and Roquefort have cardio-
protective effects because of the presence of bioactive molecules such as andrastins 
A–D and roquefortine [125]. Additionally, the cardioprotective effects of fermented 
dairy products may also be induced by the intake of bacterial metabolites and 
probiotics. Probiotics reach the gastrointestinal tract while still alive and they can 
apply their effects directly. Intake of probiotic by supplementation or consumption 
of fermented dairy products is related to possible health benefits of cardiovascular 
which include positive effects on blood pressure and hyperlipidaemia [126].
3.2 Dietary pattern and cardiovascular diseases
Various studies have associated the dietary components such as dietary fibre, 
saturated and trans fats at nutrient level; fruits, vegetables and high fat processed 
meat at food level [127–129] with changes in prevalence of CVDs. Some diet plans 
have shown the potential of reducing the incidence of CVDs (Table 4). In recent 
years, various dietary patterns have been recommended for modification in numer-
ous health outcomes apart from the normal dietary guidelines. For example, the 
Mediterranean, Dietary Approaches to Stop Hypertension (DASH), Okinawan 
Functional Foods - Phytochemicals and Health Promoting Potential
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and vegetarian diets are being promoted as healthy option. Mediterranean diet 
has gained traction and various reports have shown low incidence of CVDs among 
populations consuming this diet [137]. Plant foods and olive oil contain high anti-
oxidant content which contributes to the health of the vascular system. The DASH 
diet restricts saturated fat, red meat, sweets, and beverages with sugar. Regular 
physical exercise, high intake of dietary potassium, moderate alcohol consumption 
and low salt intake represent corroborative-based approaches to decrease blood 
pressure by DASH diet [81]. Okinawan diet restricts calorie, there is high intake of 
vegetables and legumes, moderate consumption of sea foods and alcohol as well as 
low consumption of meat and dairy products [138]. This is useful for the health of 
cardiovascular system because Okinawan diet is nutrient-dense, antioxidant-rich 
and has a low-glycaemic-load [139]. Vegetarian diet excludes meat, poultry, or fish 
and may or may not include dairy and eggs. Vegetarian dietary pattern is recognised 
for its health promoting compounds because it is rich in dietary fibre, antioxidants, 
bioactive compounds, plant protein and lower saturated than non-vegetarian 
dietary patterns [140].
4. Conclusion
Overall, this book chapter highlighted the risk factors of CVDs, functional food 
with health properties and the influence of dietary in the treatment and prevention 
of CVDs. Generally there is an increasing trend of using functional food in treating 
and preventing CVDs. Therefore, there is no doubt that functional food can exert 
a significant effect on maintenance of human health. Continual consumption of 
different types of functional foods such as fruit and vegetable, whole grains, nuts, 
legumes, tea, coffee, chocolate, fish, functional meat and fermented dairy products 
Dietary pattern High intake Moderate 
intake
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Protective effect of different dietary patterns on cardiovascular diseases.
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may help consumers and patients to lower the risk of CVDs. Consumption of 
full-fat dairy products contributes to higher intakes of important nutrients such as 
vitamin D and vitamin K. However, fermented dairy products are preferential for 
ideal intake of nutrients and possible CVDs health benefits. Dietary patterns such as 
Mediterranean, DASH, Okinawan and vegetarian should be promoted since they are 
associated with low risk of CVDs.
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